Accrued expenses consisted of the following as of December 31, 2024 and 2023 (in thousands):
December 31,
2024
2023
Accrued research and development
$
22,782
28,318
Accrued royalties
7,147
10,197
Accrued payroll liabilities
40,888
51,781
Product revenue reserves
45,145
16,625
Commercial costs
20,610
8,715
Other
3,612
12,170
Total accrued expenses
140,184
127,806
No definition available.
Tabular disclosure of the components of accrued liabilities.